1. Academic Validation
  2. Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF- κ B Pathways

Luteolin Improves Cyclophosphamide-Induced Cystitis through TXNIP/NLRP3 and NF- κ B Pathways

  • Evid Based Complement Alternat Med. 2021 Nov 11;2021:1718709. doi: 10.1155/2021/1718709.
Hengshuai Zhang 1 Jiang Zhao 1 Qudong Lu 1 Bishao Sun 1 Xin Liu 1 Chengfei Yang 1 Shuai Li 1 Longkun Li 1 Shanhong Yi 1 Zhenxing Yang 1 Jie Xu 1
Affiliations

Affiliation

  • 1 Department of Urology, Second Affiliated Hospital, Army Medical University, Chongqing 400037, China.
Abstract

Hemorrhagic cystitis is an important complication of cyclophosphamide chemotherapy, and current therapies for the disease are limited. The natural flavonoid luteolin (LUT) has significant anti-inflammatory and antioxidant properties, but its protective effect on cyclophosphamide (CYP)-induced bladder toxicity has yet to be evaluated. This study aims to explore the protective effect of LUT on CYP-induced acute cystitis in rats. Female Sprague-Dawley rats were randomly assigned to the control (CON) group, CON + LUT group, CYP group, and CYP + LUT group. A single intraperitoneal injection of CYP was administered to establish an acute hemorrhagic cystitis model. HE staining was performed to detect the degree of bladder tissue damage, and TUNEL staining was performed to count apoptotic cells. Oxidative stress indicators were measured using commercial kits, and bladder surgery was performed to assess urinary function. The levels of inflammatory cytokines, apoptosis-related indicators, TXNIP/NLRP3 pathway, and NF-κB pathway were detected by western blot. We found that LUT treatment reduced bladder bleeding, congestion, and edema caused by CYP. Compared with the CYP + LUT group, the level of Apoptosis was more highly expressed in the CYP group. We also found that Caspase-3, Caspase-8, and Bax were significantly upregulated and Bcl-2 was downregulated after LUT treatment. In addition, LUT inhibited the activation of NF-κB signal pathway in the rat bladder tissue after CYP exposure. LUT treatment can also reduce the NLRP3 inflammasome (NLRP3, ASC, and Caspase-1) and TXNIP in the bladder. Finally, LUT can reduce the increase in the urination frequency and maximum urination pressure caused by cystitis. These results indicate that LUT displays effective anti-inflammatory, antioxidant, and antiapoptotic properties in CYP-induced acute hemorrhagic cystitis rats by inhibiting the TXNIP/NLRP3 and NF-κB pathways. LUT may be a potent therapeutic agent for the prevention and treatment of hemorrhagic cystitis.

Figures
Products